OrbiMed Capital GP V LLC's Net Worth
$0
Who is OrbiMed Capital GP V LLC?
OrbiMed Capital GP V LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., RHYTHM PHARMACEUTICALS, INC., PMV Pharmaceuticals, Inc., SI-BONE, Inc., Intellia Therapeutics, Inc., Inspire Medical Systems, Inc., Aadi Bioscience, Inc., Tricida, Inc., Adaptimmune Therapeutics PLC, ARMO BioSciences, Inc., Loxo Oncology, Inc., Nabriva Therapeutics AG, Dimension Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Compass Therapeutics, Inc., and Corvus Pharmaceuticals, Inc..
SEC CIK
OrbiMed Capital GP V LLC's CIK is 0001615374
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adicet Bio, Inc. (ACET) Snapshot price: $1.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.01% | 3.13M |
$2.40 | $7,500,000.00 | 9.77M |
Jan 25
| |||
Form 4
| +12.10% | 875K |
$2.09 | $1,828,750.00 | 8.11M |
Jun 27
| |||
Form 4
| +765.30% | 214.28K |
$14.00 | $2,999,990.00 | 242.28K |
Dec 10
| |||
Form 4
| +10.25% | 524.35K |
$13.00 | $6,816,537.00 | 5.64M |
Feb 12
| |||
Form 4
|
∞
| 6.02M |
—
|
—
| 6.02M |
Sep 15 - Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.71% | -19.58K |
$30.43 | -$595,768.40 | 2.75M |
May 22
| |||
Form 4
| -4.54% | -131.64K |
$30.88 | -$4,065,439.72 | 2.77M |
May 18 - May 21
| |||
Form 4
|
∞
| 2.9M |
$17.00 |
—
| 2.9M |
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.6588
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -87.79K |
$2.23 | -$195,762.78 |
0
|
Nov 22
| |||
Form 4
| -23.02% | -26.25K |
$15.93 | -$418,210.29 | 87.79K |
May 26
| |||
Form 4
| -100.00% | -474.50K |
$21.63 | -$10,264,415.00 |
0
|
Mar 29 - Mar 31
| |||
Form 4
|
∞
| 7.06M |
$18.00 | $8,550,000.00 | 7.06M |
Sep 25 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SI-BONE, Inc. (SIBN) Snapshot price: $15.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 985.37K |
$15.00 |
—
| 985.37K |
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.66M |
$18.00 |
—
| 2.66M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |